A Study to Create a Biobank of Fallopian Tube Organoids (Small, Simplified Organs) in Women Undergoing Salpingectomy (Surgical Removal of the Fallopian Tubes)


About this study

The aim of this study is to develop and bank organoids for collaborative use in subsequent etiological, biomarker and chemoprevention studies that will culminate in launching chemoprevention trials at Mayo.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All women undergoing salpingectomy surgeries are eligible.
  • Age ≥ 18 years must be able to understand and willing to sign an informed consent document.

Exclusion Criteria:

  • Any history of or currently having medical conditions that prohibit the understanding or rendering of informed consent such as dementia, altered mental status, psychiatric conditions.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nagarajan Kannan, Ph.D., M.S.

Open for enrollment

Contact information:

Kaitlin Schwartz

(507) 293-9114


Jacksonville, Fla.

Mayo Clinic principal investigator

Nagarajan Kannan, Ph.D., M.S.

Contact us for the latest status

Contact information:

Kimberly McCoy



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer